Market Overview:
The global ADME-Tox screening systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for ADME-Tox screening systems for drug discovery and development, biopharmaceutical production, and tissue engineering applications. Additionally, the growing focus on personalized medicine is also contributing to the growth of this market. North America dominates the global ADME-Tox screening systems market followed by Europe and Asia Pacific.
Product Definition:
ADME-Tox Screening Systems is a set of tests used to determine how well a drug is absorbed, distributed, metabolized and eliminated from the body. The results of these tests can help predict how a drug will behave in humans. ADME-Tox Screening Systems are important because they can help identify potential problems with new drugs before they are tested in humans.
Instruments:
Instruments are used for measuring the potency of test compounds. They are also used to standardize and quantitate the concentration of drug molecules in samples. The most commonly employed instruments in ADME-Tox screening systems include high performance liquid chromatography (HPLC), mass spectrometry, and ultraviolet-visible (UV) spectroscopy.
Assay system:
An assay system is a computer-controlled device used for measuring the quantity of target analyte in samples. It helps to identify new compounds and check their potency, efficacy, and safety. ADME-Tox Screening Systems market includes devices such as high performance liquid chromatography (HPLC), mass spectrometry, surface plasmon resonance (SPR), enzyme immunoassay (EIA) systems etc., which are used for drug discovery & development processes.
Application Insights:
The discovery and development segment dominated the global ADME-Tox screening systems market in 2017. This can be attributed to the rising number of pipeline products with a high potential for abuse that are currently under investigation. For instance, according to clinical trial data published in 2018 by FDA, around 70% of all new drug applications are accepted based on preclinical data.
In addition, factors such as increasing government funding for ADME-Tox assays and growing concerns regarding adverse events associated with these drugs during clinical trials are expected to drive product demand over the forecast period. The biopharmaceutical production segment is anticipated to witness lucrative growth over the forecast period owing to factors such as an increase in government support for biosimilars production and stringent regulations pertaining bio-production facilities across various countries worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, increased funding for ADME-Tox research and development activities, and high adoption of ADME-Tox screening systems in U.S. Furthermore, increasing number of FDA approvals for new products is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising investments by governments & private entities as well as increasing R&D expenditure by pharmaceutical companies in this region due to low cost associated with Asian countries compared with developed nations like U.S., UK, Germany etc.
Growth Factors:
- Increasing demand for drugs and growing number of new drug approvals: The global market for pharmaceuticals is expected to grow at a CAGR of 6.5% from 2016 to 2020, reaching a value of US$ 1,059.8 billion by 2020. This growth is primarily attributed to the increasing demand for drugs and the growing number of new drug approvals. The increase in R&D expenditure by pharmaceutical companies is also contributing to the growth of this market
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is rising globally due to changing lifestyles and aging population. This is leading to an increase in the demand for novel therapeutics and propelling the growth of the ADME-Tox screening systems market
- Technological advancements: Advancements in technology are resulting in innovative products with better performance characteristics being launched into the market place on a regular basis .This is driving demand for better ADME-Tox screening systems that can provide faster turnaround times with accurate results
Scope Of The Report
Report Attributes
Report Details
Report Title
ADME-Tox Screening Systems Market Research Report
By Type
Instruments, Assay system, Software
By Application
Discovery and Development, Biopharmaceutical Production, Drug Screening, Tissue Engineering, Others
By Companies
Hudson Robotics, Agilent Tsechnologies, ADMEcell, BioreclamationIVT, Beckman Counter, Cerep, Hudson Robotics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global ADME-Tox Screening Systems Market Report Segments:
The global ADME-Tox Screening Systems market is segmented on the basis of:
Types
Instruments, Assay system, Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Discovery and Development, Biopharmaceutical Production, Drug Screening, Tissue Engineering, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hudson Robotics
- Agilent Tsechnologies
- ADMEcell
- BioreclamationIVT
- Beckman Counter
- Cerep
- Hudson Robotics
Highlights of The ADME-Tox Screening Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Assay system
- Software
- By Application:
- Discovery and Development
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the ADME-Tox Screening Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
ADME-Tox Screening Systems are a type of laboratory testing that can help identify potential toxins in the body. These systems use a variety of tests to look for chemicals that may be causing health problems.
Some of the key players operating in the adme-tox screening systems market are Hudson Robotics, Agilent Tsechnologies, ADMEcell, BioreclamationIVT, Beckman Counter, Cerep, Hudson Robotics.
The adme-tox screening systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 ADME-Tox Screening Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 ADME-Tox Screening Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 ADME-Tox Screening Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the ADME-Tox Screening Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global ADME-Tox Screening Systems Market Size & Forecast, 2018-2028
4.5.1 ADME-Tox Screening Systems Market Size and Y-o-Y Growth
4.5.2 ADME-Tox Screening Systems Market Absolute $ Opportunity
Chapter 5 Global ADME-Tox Screening Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 ADME-Tox Screening Systems Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Assay system
5.2.3 Software
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global ADME-Tox Screening Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 ADME-Tox Screening Systems Market Size Forecast by Applications
6.2.1 Discovery and Development
6.2.2 Biopharmaceutical Production
6.2.3 Drug Screening
6.2.4 Tissue Engineering
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global ADME-Tox Screening Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 ADME-Tox Screening Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America ADME-Tox Screening Systems Analysis and Forecast
9.1 Introduction
9.2 North America ADME-Tox Screening Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America ADME-Tox Screening Systems Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Assay system
9.6.3 Software
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America ADME-Tox Screening Systems Market Size Forecast by Applications
9.10.1 Discovery and Development
9.10.2 Biopharmaceutical Production
9.10.3 Drug Screening
9.10.4 Tissue Engineering
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe ADME-Tox Screening Systems Analysis and Forecast
10.1 Introduction
10.2 Europe ADME-Tox Screening Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe ADME-Tox Screening Systems Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Assay system
10.6.3 Software
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe ADME-Tox Screening Systems Market Size Forecast by Applications
10.10.1 Discovery and Development
10.10.2 Biopharmaceutical Production
10.10.3 Drug Screening
10.10.4 Tissue Engineering
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific ADME-Tox Screening Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific ADME-Tox Screening Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific ADME-Tox Screening Systems Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Assay system
11.6.3 Software
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific ADME-Tox Screening Systems Market Size Forecast by Applications
11.10.1 Discovery and Development
11.10.2 Biopharmaceutical Production
11.10.3 Drug Screening
11.10.4 Tissue Engineering
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America ADME-Tox Screening Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America ADME-Tox Screening Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America ADME-Tox Screening Systems Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Assay system
12.6.3 Software
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America ADME-Tox Screening Systems Market Size Forecast by Applications
12.10.1 Discovery and Development
12.10.2 Biopharmaceutical Production
12.10.3 Drug Screening
12.10.4 Tissue Engineering
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) ADME-Tox Screening Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) ADME-Tox Screening Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) ADME-Tox Screening Systems Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Assay system
13.6.3 Software
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) ADME-Tox Screening Systems Market Size Forecast by Applications
13.10.1 Discovery and Development
13.10.2 Biopharmaceutical Production
13.10.3 Drug Screening
13.10.4 Tissue Engineering
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 ADME-Tox Screening Systems Market: Competitive Dashboard
14.2 Global ADME-Tox Screening Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hudson Robotics
14.3.2 Agilent Tsechnologies
14.3.3 ADMEcell
14.3.4 BioreclamationIVT
14.3.5 Beckman Counter
14.3.6 Cerep
14.3.7 Hudson Robotics
